- Home
- DTST vs SCLX Comparison
DTST vs SCLX Comparison
Compare DTST & SCLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DTST
- SCLX
- Stock Information
- Founded
- DTST 2001
- SCLX 2011
- Country
- DTST United States
- SCLX United States
- Employees
- DTST N/A
- SCLX N/A
- Industry
- DTST EDP Services
- SCLX Biotechnology: Pharmaceutical Preparations
- Sector
- DTST Technology
- SCLX Health Care
- Exchange
- DTST Nasdaq
- SCLX Nasdaq
- Market Cap
- DTST 32.6M
- SCLX 35.7M
- IPO Year
- DTST N/A
- SCLX N/A
- Fundamental
- Price
- DTST $4.61
- SCLX $26.28
- Analyst Decision
- DTST
- SCLX Strong Buy
- Analyst Count
- DTST 0
- SCLX 3
- Target Price
- DTST N/A
- SCLX $367.50
- AVG Volume (30 Days)
- DTST 75.9K
- SCLX 230.4K
- Earning Date
- DTST 11-13-2025
- SCLX 08-13-2025
- Dividend Yield
- DTST N/A
- SCLX N/A
- EPS Growth
- DTST N/A
- SCLX N/A
- EPS
- DTST N/A
- SCLX N/A
- Revenue
- DTST $25,455,742.00
- SCLX $44,236,000.00
- Revenue This Year
- DTST $12.57
- SCLX $89.26
- Revenue Next Year
- DTST $9.29
- SCLX $203.95
- P/E Ratio
- DTST N/A
- SCLX N/A
- Revenue Growth
- DTST 0.53
- SCLX N/A
- 52 Week Low
- DTST $2.93
- SCLX $3.60
- 52 Week High
- DTST $5.44
- SCLX $41.30
- Technical
- Relative Strength Index (RSI)
- DTST 53.94
- SCLX 76.74
- Support Level
- DTST $4.42
- SCLX $23.90
- Resistance Level
- DTST $4.70
- SCLX $19.73
- Average True Range (ATR)
- DTST 0.11
- SCLX 1.85
- MACD
- DTST -0.01
- SCLX 0.50
- Stochastic Oscillator
- DTST 64.41
- SCLX 91.79
About DTST Data Storage Corporation
Data Storage Corporation engages in providing cybersecurity, compliance and cloud computing solutions. The company's segment includes Nexxis Inc; CloudFirst Europe Ltd and CloudFirst Technologies Corporation and Corporate. It generates maximum revenue from the CloudFirst Technologies Corporation segment. The company's solutions include infrastructure, disaster recovery, email archival, compliance, electronic vaulting, virtualized recovery, telecom recovery services, and continuous data protection.
About SCLX Scilex Holding Company
Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for relieving pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.